Use of specific immunotherapy – a survey of 15 164 employed persons in Germany

T. Weberschock,I. Schaefer,H. Heigel,E. Valesky,M. Augustin,J. Schmitt
DOI: https://doi.org/10.1111/ddg.12298
2014-04-01
Abstract:The high prevalence of allergic rhinitis (AR) leads to high morbidity and costs. Specific immunotherapy (SIT) is a potentially curative therapy for AR. The decision whether or not to employ SIT is often not totally clear.
What problem does this paper attempt to address?